On July 31, 2026, the final five updated monographs, Benzocaine, Figwort, Hawthorn, Marigold extracts and isolates (lutein and zeaxanthin), and Mugwort were published, successfully concluding the monograph revision project initiated in 2023. Additionally, the Beta-glucan monograph was expanded to include yeast beta-glucan along with its associated medicinal ingredient details, claims, dosages, and risk statements. Following these releases, plans were set for August to address minor stakeholder edits before shifting focus toward developing new monographs, beginning with analyzing public consultation feedback on Tongkat ali and Nigella sativa ahead of an upcoming technical session.
